Get Real Time Here
| Open9.930 | Close9.820 |
| Vol / Avg.4.402M / 8.728M | Mkt Cap11.008B |
| Day Range9.800 - 9.980 | 52 Wk Range7.085 - 11.445 |
Teva Pharmaceutical Indus Stock (NYSE:TEVA), Quotes and News Summary
Teva Pharmaceutical Indus Stock (NYSE: TEVA) stock price, news, charts, stock research, profile.
| Open9.930 | Close9.820 |
| Vol / Avg.4.402M / 8.728M | Mkt Cap11.008B |
| Day Range9.800 - 9.980 | 52 Wk Range7.085 - 11.445 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.610 | 0.600 | -0.0100 | ||||
| REV | 3.720B | 3.850B | 130.000M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-11-27 | UBS | Ashwani Verma | Upgrades | NeutralBuy | Raises | 11.00 | 13.00 |
| 2023-09-20 | UBS | Ashwani Verma | Maintains | NeutralNeutral | Raises | 8.00 | 11.00 |
| 2023-09-08 | B of A Securities | Jason Gerberry | Maintains | BuyBuy | Raises | 12.00 | 13.00 |
| 2023-07-06 | UBS | Ashwani Verma | Upgrades | SellNeutral | Raises | 7.00 | 8.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| TEVA | Teva Pharmaceutical Indus | -1.5% | 11B |
| NVO | Novo Nordisk | 0.06% | 432B |
| JNJ | Johnson & Johnson | -0.64% | 371.7B |
| MRK | Merck & Co | -0.42% | 262.1B |
| NVS | Novartis | 0.19% | 197.6B |
How do I buy Teva Pharmaceutical Indus (TEVA) stock?
You can purchase shares of Teva Pharmaceutical Indus (NYSE: TEVA) through any online brokerage.
Who are Teva Pharmaceutical Indus's (TEVA) competitors?
Other companies in Teva Pharmaceutical Indus’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
What is the target price for Teva Pharmaceutical Indus (TEVA) stock?
The latest price target for Teva Pharmaceutical Indus (NYSE: TEVA) was reported by UBS on Monday, November 27, 2023. The analyst firm set a price target for 13.00 expecting TEVA to rise to within 12 months (a possible 32.38% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Teva Pharmaceutical Indus (TEVA)?
The stock price for Teva Pharmaceutical Indus (NYSE: TEVA) is $9.82 last updated December 8, 2023 at 9:00 PM UTC.
Does Teva Pharmaceutical Indus (TEVA) pay a dividend?
A quarterly cash dividend of $0.09 per share of Class A Common Stock. The quarterly cash dividend was payable on December 12, 2017 to stockholders of record on November 28, 2017.
When is Teva Pharmaceutical Indus (NYSE:TEVA) reporting earnings?
Teva Pharmaceutical Indus’s Q4 earnings are confirmed for Wednesday, February 7, 2024.
Is Teva Pharmaceutical Indus (TEVA) going to split?
There is no upcoming split for Teva Pharmaceutical Indus.
What sector and industry does Teva Pharmaceutical Indus (TEVA) operate in?
Teva Pharmaceutical Indus is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.